Surmodics Inc (SRDX): Kapitalisasi marang pendapatan
Surmodics, Inc. (SRDX) ensures a stable output of sterile catheters through its own manufacturing facilities in the US and Ireland. This price-to-sales chart from the GURU.Markets terminal shows the value has stabilized at 5.10. Revenues are based on licensing royalties for unique coatings. Strong pricing power and patents for chemical compositions minimize the risks of component substitution in partners' products.
Rincian analitis perusahaan Surmodics Corp (SRDX)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Surmodics, Inc.|SRDX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Surmodics Inc.|SRDX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Surmodics Corp|SRDX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Surmodics|Rasio jangkoan perantara surmodics.com
- data bathi lan kelipatan valuasi:
SRDX - Bathi resik|Bathi resik sing dikarepake Surmodics, Inc.|SRDX - Rasio rega marang bathi|Pangali forward rega marang bathi Surmodics Inc|SRDX - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Surmodics Corp|SRDX - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Surmodics|SRDX - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan surmodics.com|SRDX - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Surmodics, Inc.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:SRDX surmodics.com
The P/S ratio compares the market capitalization of Surmodics, Inc. (SRDX) to its annual revenue, determining the value of each dollar of sales in the eyes of investors. Analyzing the P/S multiple can reveal asset overvaluation, particularly when the efficiency of chemical production outsourcing and cloud logistics fails to provide a proportional acceleration in the company's revenue growth rates.
Pesaing Surmodics, Inc.
DXCM (dexcom.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Penumbra PEN|NOVT - Kapitalisasi marang pendapatan|Haemonetics Corp. - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems Inc|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Biosciences) - Multiplikator P/S|InMode Ltd (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Eversense SENS|Multiplikator P/S NPCE (NeuroPace, Inc.)|Multiplikator P/S Tactile Systems Technology, Inc. TCMD|SNWV - Rasio rega marang pendapatan|OM: Rasio rega marang pendapatan|ELMD (smartvest.com) - Kapitalisasi marang pendapatan|LENSAR Inc - Rasio kapitalisasi pasar marang pendapatan|RCEL (AVITA Medical, Inc.) - Multiplikator P/S|Rega marang dodolan Profound Medical Corporation PROF|Rasio rega marang pendapatan Baird Medical Investment (BDMD)|edap-tms.com (EDAP) - Multiplikator rega marang pendapatan|Apyx Medical Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S IceCure Medical Ltd. ICCM|Pulmonx Corp. - Multiplikator P/S|Koefisien rega marang pendapatan TELA Bio, Inc. TELA|cytosorbents.com (CTSO) - Rasio rega marang pendapatan|Rasio rega marang dodolan SRTS (Sensus Healthcare Inc)|Rasio rega marang pendapatan Zynex Inc|Kapitalisasi marang pendapatan electroCore Medical (ECOR)|Multiplikator P/S RBOT|IINN - Rega marang dodolan|Rasio rega marang pendapatan SeaStar Medical ICU|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|Beyond Air, Inc. - Kapitalisasi marang volume dodolan|Profusa Inc (PFSA) - Rasio rega marang pendapatan|SSKN - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan GCTK|Multiplikator P/S nanovibronix.com|Rasio rega marang pendapatan Venus Concept Corp (VERO)|NUWE (Nuwellis Corp) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Aethlon Medical AEMD|ASXC - Kapitalisasi marang pendapatan|AVGR - Rasio rega marang pendapatan|Rega marang dodolan BioSig|CUTR: Multiplikator P/S|Rasio kapitalisasi marang pendapatan KNW|NARI (Inari Medical, Inc.) - Multiplikator P/S|nevro.com (NVRO) - Koefisien rega marang pendapatan|Multiplikator P/S RSLS|Kapitalisasi marang pendapatan Silk Road Medical, Inc. SILK
